as on January 10, 2026 at 2:29 am IST
Day's Low
Day's High
3.34%
Downside
0.46%
Upside
52 Week's Low
52 Week's High
64.13%
Downside
34.88%
Upside
Check Neogenomics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.7B
EPS (TTM)
0.0973
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
1.31%
PE Ratio (TTM)
-26.79
Industry PE ratio
7.264444444444444
PEG Ratio
3.02
EBITDA
-3.4M
Revenue (TTM)
709.2M
Profit Margin
-16.00%
Return On Equity TTM
-12.99%
Track how Neogenomics, Inc. P/E has moved over time to understand its valuation trends.
Neogenomics, Inc. in the last 5 years
Lowest (-173.72x)
December 31, 2024
Today (-26.79x)
January 10, 2026
Industry (7.26x)
January 10, 2026
Highest (-15.52x)
September 30, 2022
Today’s Price to Earnings Ratio: -26.79x
Compare market cap, revenue, PE, and other key metrics of Neogenomics, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.7B | -74.9% | -26.79 | -16.00% |
The Neogenomics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Neogenomics, Inc. investment value today
Current value as on today
₹93,711
Returns
Returns from Neogenomics, Inc. Stock
Dollar Returns*
₹4,612 (+4.61%)
Based on 17 analysts
76.47%
Buy
23.53%
Hold
0.00%
Sell
Based on 17 analysts, 76.47% of analysts recommend a 'BUY' rating for Neogenomics, Inc.. Average target price of $14.56
Get share price movements and forecasts by analysts on Neogenomics, Inc..
What analysts predicted
9.62%UPSIDE
Target Price
$14.56
Current Price
$13.16
Analyzed by
17 Analysts
Target
$14.56
Neogenomics, Inc. target price $14.56, a slight upside of 9.62% compared to current price of $13.16. According to 17 analysts rating.
Search interest for Neogenomics, Inc. Stock has decreased by -50% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 16 October
Thu, 11:35 AM
-NeoGenomics shares climbed over 8% this week, reflecting renewed investor interest amid long-term challenges.
Thu, 01:24 PM
-NeoGenomics shares rose 6.3% to $9.97, driven by positive investor expectations and upcoming clinical data presentations.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, NEO stock has moved up by 13.0%
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -45.09M → -27.12M (in $), with an average increase of 66.2% per quarter
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 168.03M → 187.79M (in $), with an average increase of 5.4% per quarter
Price Rise
![]()
In the last 3 months, NEO stock has moved up by 44.6%
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 47.03% of holdings in Sep 2025 quarter
Against Peers
![]()
In the last 3 years, Idexx Laboratories, Inc. has given 52.1% return, outperforming this stock by 26.2%
Retail Holding Unchanged
![]()
Retail Investor holdings remained unchanged at 52.97% of holdings in Sep 2025 quarter
Against Peers
![]()
In the last 1 year, Idexx Laboratories, Inc. has given 70.6% return, outperforming this stock by 81.5%
| Organisation | Neogenomics, Inc. |
| Headquarters | 9490 NeoGenomics Way, Fort Myers, FL, United States, 33912 |
| Industry | Health Services |
| CEO | Mr. Anthony P. Zook |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Anthony P. Zook | CEO & Director |
Mr. Jeffrey S. Sherman M.B.A. | Chief Financial Officer |
Mr. Gary Passman | Chief People & Culture Officer |
Mr. Warren Stone | President & COO |
Ms. Elizabeth A. Floegel | Chief Digital & Information Officer |
Ms. Alicia C. Olivo | Executive VP of Business Development, General Counsel & Corporate Secretary |
Mr. Gregory D. Aunan | Senior VP & Chief Accounting Officer |
Ms. Kendra Sweeney | Vice President of Investor Relations & Communications |
Mr. Clarence Cooper Esq. | Vice President of Compliance & Privacy |
Mr. Kareem M. Saad | Head of Strategy, Business Development & Transformation |
Neogenomics, Inc. share price today is $13.16 as on at the close of the market. Neogenomics, Inc. share today touched a day high of $13.22 and a low of $12.72.
Neogenomics, Inc. share touched a 52 week high of $17.75 on and a 52 week low of $4.72 on . Neogenomics, Inc. stock price today i.e. is closed at $13.16,which is 25.86% down from its 52 week high and 178.81% up from its 52 week low.
Neogenomics, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Neogenomics, Inc. (NEO) shares with as little as ₹90.17 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹901.70 in Neogenomics, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Neogenomics, Inc. share’s latest price of $13.16 as on January 10, 2026 at 2:29 am IST, you will get 0.7599 shares of Neogenomics, Inc.. Learn more about
fractional shares .
Neogenomics, Inc. stock has given -74.9% share price returns and 22.31% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?